A Phase 1 Dose Escalation Study of Oral VX-708 in Healthy Participants

NCT05347394 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Pain

Interventions

DRUG: VX-708
DRUG: Placebo

Sponsor

Vertex Pharmaceuticals Incorporated